--- title: "Semaglutide vs Dulaglutide India" description: "Semaglutide vs dulaglutide in India: weekly GLP-1 comparison, cost bands, efficacy context, and RSSDI prescribing for Indian type 2 diabetes patients." canonical: "https://www.kesho.health/keywords/semaglutide-vs-dulaglutide" markdown_url: "https://www.kesho.health/md/keywords/semaglutide-vs-dulaglutide" language: "en-IN" primary_keyword: "semaglutide vs dulaglutide India" --- # Semaglutide vs dulaglutide — weekly GLP-1 in India > **Short answer:** Semaglutide and dulaglutide are both weekly GLP-1 receptor agonists available in India for type 2 diabetes. Semaglutide often shows stronger weight and HbA1c effects in trials; dulaglutide may suit selected patients per physician choice. Cost and generic availability differ by city—compare CDSCO-approved quotes. **Canonical HTML:** https://www.kesho.health/keywords/semaglutide-vs-dulaglutide **Markdown:** https://www.kesho.health/md/keywords/semaglutide-vs-dulaglutide ## Weekly GLP-1 choice **Check chemist quote** — Compare a pharmacy quote against typical CDSCO-approved GLP-1 ranges — spot grey-market pricing before you pay. [Check chemist quote](https://www.kesho.health/chemist-quote-check) **GLP-1 readiness check** — Educational self-assessment on eligibility signals, safety flags, and what to discuss with your doctor — not a prescription. [GLP-1 readiness check](https://www.kesho.health/glp-1-assessment) ## What are semaglutide and dulaglutide? Both molecules belong to the GLP-1 receptor agonist drug class approved for type 2 diabetes under Schedule H prescription—not interchangeable without physician supervision. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## How do injection devices differ? Single-use pens and storage requirements differ by manufacturer—read package inserts for in-use expiry and refrigeration rules during Indian summer travel. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## What do trials suggest about efficacy differences? Trial networks show semaglutide with robust weight and HbA1c reductions; dulaglutide remains an established weekly option in RSSDI treatment algorithms for selected profiles. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## How do monthly costs compare in Indian pharmacies? Generic semaglutide availability may alter relative pricing versus dulaglutide in 2026—collect itemised quotes at maintenance dose before choosing solely on cost. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## Who might prefer dulaglutide in Indian practice? Physicians may select dulaglutide when prior semaglutide intolerance occurred or when formulary availability favours specific hospital contracts. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## Can patients switch between weekly GLP-1 molecules? Switching weekly GLP-1 molecules requires washout intervals and retitration—never alternate pens without prescriber guidance. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## What titration rules apply to both? Both require gradual dose escalation to limit nausea during first months of therapy. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## How does CDSCO approval status compare? Verify CDSCO-approved inserts for both molecules at licensed pharmacies—reject unlabeled research products. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## Where is the semaglutide complete guide on Kesho? Our semaglutide guide covers drug-class context applicable across weekly GLP-1 options with India-specific cost and safety sections. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill. RSSDI and ICMR guidance emphasise structured lifestyle support alongside pharmacotherapy for South Asian metabolic risk. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. ## Quick questions ### Is Semaglutide vs Dulaglutide India information on Kesho medical advice? No. Kesho provides drug-class education only. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised treatment decisions. ### Where is the full guide? See our complete medically reviewed guide linked on this page for in-depth coverage with references and India-specific context. ### What is the short answer on semaglutide vs dulaglutide india? Semaglutide and dulaglutide are both weekly GLP-1 receptor agonists available in India for type 2 diabetes. Semaglutide often shows stronger weight and HbA1c effects in trials; dulaglutide may suit selected patients per physician choice. Cost and generic availability differ by city—compare CDSCO-approved quotes. ## Complete guide [semaglutide-india-complete-guide](https://www.kesho.health/blog/semaglutide-india-complete-guide) · [MD](https://www.kesho.health/md/blog/semaglutide-india-complete-guide) ## Related guides - [Dulaglutide in India](https://www.kesho.health/keywords/dulaglutide-india) - [Semaglutide in India](https://www.kesho.health/keywords/semaglutide-india) - [Semaglutide vs liraglutide in India — weekly vs daily GLP-1](https://www.kesho.health/compare/semaglutide-vs-liraglutide) --- *Drug-class education only — not medical advice. [Kesho](https://www.kesho.health)*